ARTICLE | Clinical News
Nucleic acid binding agents regulatory update
December 4, 2000 8:00 AM UTC
CERS received U.S. Patent No. 6,143,490 covering the use of certain types of chemical compounds that bind DNA or RNA, such as CERS' S-303 pH-activated anchor-linker-effector (ALE) Helinx compound, to ...